{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:44Z","timestamp":1793316584754,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pharmthera.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,7]],"date-time":"2014-09-07T08:06:32Z","timestamp":1410077192000},"page":"35-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["The iron-regulatory hormone hepcidin: A possible therapeutic target?"],"prefix":"10.1016","volume":"146","author":[{"given":"Luc","family":"Rochette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Gudjoncik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Guenancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vergely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2014.09.004_bb0005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.bcp.2006.02.009","article-title":"Molecular targets of dietary agents for prevention and therapy of cancer","volume":"71","author":"Aggarwal","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0010","article-title":"Crosstalk between the Smad and the mitogen-activated protein kinase pathways is essential for erythroid differentiation of erythroleukemia cells induced by TGF-beta, activin, hydroxyurea and butyrate","volume":"1","author":"Akel","year":"2013","journal-title":"J Leuk (Los Angel)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0015","first-page":"245","article-title":"The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis","volume":"1836","author":"Alkhateeb","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0020","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/ijo.2010.204","article-title":"Effect of body mass index reduction on serum hepcidin levels and iron status in obese children","volume":"34","author":"Amato","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.04.044","article-title":"Anemia and chronic heart failure implications and treatment options","volume":"52","author":"Anand","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio0108-15","article-title":"Small-molecule dissection of BMP signaling","volume":"4","author":"Anderson","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0035","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00018-009-0051-1","article-title":"Mammalian iron transport","volume":"66","author":"Anderson","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.335","article-title":"BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism","volume":"41","author":"Andriopoulos","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0045","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0050","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.nut.2008.11.030","article-title":"Vitamin A deficiency increases hepcidin expression and oxidative stress in rat","volume":"25","author":"Arruda","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0060","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin","volume":"95","author":"Ashby","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0070","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tem.2013.07.003","article-title":"When less is more: novel mechanisms of iron conservation","volume":"24","author":"Bayeva","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.gastro.2006.07.007","article-title":"Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH","volume":"131","author":"Bekri","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2012-02-411470","article-title":"Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1\/5\/8 signaling","volume":"120","author":"Besson-Fournier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0090","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCRESAHA.113.301656","article-title":"Liver X receptor activation stimulates iron export in human alternative macrophages","volume":"113","author":"Bories","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0095","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1074\/jbc.M111.282350","article-title":"Identification of interaction sites for dimerization and adapter recruitment in Toll\/interleukin-1 receptor (TIR) domain of Toll-like receptor 4","volume":"287","author":"Bovijn","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1189\/jlb.0807553","article-title":"Regulation of superoxide production in neutrophils: role of calcium influx","volume":"84","author":"Brechard","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2014.00045","article-title":"Labile iron in cells and body fluids: physiology, pathology, and pharmacology","volume":"5","author":"Cabantchik","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000531","article-title":"Iron-regulatory proteins: molecular biology and pathophysiological implications","volume":"9","author":"Cairo","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0115","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1242\/jcs.03228","article-title":"TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway","volume":"119","author":"Calzolari","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ng0409-386","article-title":"BMP6 orchestrates iron metabolism","volume":"41","author":"Camaschella","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/ehm.10.2","article-title":"Iron-deficiency anemia secondary to mutations in genes controlling hepcidin","volume":"3","author":"Cau","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1542-4758.2012.00716.x","article-title":"Simvastatin downregulates the expression of hepcidin and erythropoietin in HepG2 cells","volume":"17","author":"Chang","year":"2013","journal-title":"Hemodial Int"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.jrn.2011.09.007","article-title":"Vitamin C affects the expression of hepcidin and erythropoietin receptor in HepG2 cells","volume":"22","author":"Chiu","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0140","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/jn\/137.11.2366","article-title":"Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells","volume":"137","author":"Chung","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bip.22350","article-title":"Design, synthesis, and characterization of cyclic analogues of the iron regulatory peptide hormone hepcidin","volume":"100","author":"Clark","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chembiol.2010.12.009","article-title":"Understanding the structure\/activity relationships of the iron regulatory peptide hepcidin","volume":"18","author":"Clark","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00000542-200201000-00019","article-title":"Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass","volume":"96","author":"Clermont","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/obr.12057","article-title":"The role of adipocytes in the modulation of iron metabolism in obesity","volume":"14","author":"Coimbra","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0165","doi-asserted-by":"crossref","first-page":"G229","DOI":"10.1152\/ajpgi.00092.2006","article-title":"Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation","volume":"291","author":"Constante","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0170","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2010.07.044","article-title":"BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice","volume":"139","author":"Corradini","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0175","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1097\/00003246-200008000-00079","article-title":"Anemia of the critically ill: \u201cacute\u201d anemia of chronic disease","volume":"28","author":"Corwin","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1472-8206.1998.tb00947.x","article-title":"Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction","volume":"12","author":"Cottin","year":"1998","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0185","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.bmcl.2008.06.052","article-title":"Structure\u2013activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors","volume":"18","author":"Cuny","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ijo.2012.28","article-title":"Activins in adipogenesis and obesity","volume":"37","author":"Dani","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","article-title":"The transferrin receptor and the targeted delivery of therapeutic agents against cancer","volume":"1820","author":"Daniels","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10534-008-9187-y","article-title":"Interacting signals in the control of hepcidin expression","volume":"22","author":"Darshan","year":"2009","journal-title":"Biometals"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0205","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1073\/pnas.0900453106","article-title":"Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2","volume":"106","author":"De Domenico","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0210","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1091\/mbc.e07-01-0060","article-title":"The molecular mechanism of hepcidin-mediated ferroportin down-regulation","volume":"18","author":"De Domenico","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0215","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archinte.159.14.1542","article-title":"Iron, atherosclerosis, and ischemic heart disease","volume":"159","author":"de Valk","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2010.08349.x","article-title":"Genetic variability of TMPRSS6 and its association with iron deficiency anaemia","volume":"151","author":"Delbini","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0225","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.25689","article-title":"Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice","volume":"56","author":"Delima","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0230","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/humu.22396","article-title":"Ferroportin diseases: functional studies, a link between genetic and clinical phenotype","volume":"34","author":"Detivaud","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-4680(02)00054-8","article-title":"Prevention of apoptosis by deferoxamine during 4hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model","volume":"9","author":"Dobsak","year":"2002","journal-title":"Pathophysiology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0240","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/rheumatology\/kes381","article-title":"Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial","volume":"52","author":"Doyle","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0245","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/nu5093730","article-title":"Iron deficiency in heart failure: a practical guide","volume":"5","author":"Ebner","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0250","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gut.2010.214312","article-title":"Iron sensing and signalling","volume":"61","author":"Evstatiev","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0255","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00109-009-0588-3","article-title":"Natural and synthetic STAT3 inhibitors reduce hepcidin expression in differentiated mouse hepatocytes expressing the active phosphorylated STAT3 form","volume":"88","author":"Fatih","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0260","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/gut.2003.037416","article-title":"Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis","volume":"53","author":"Frazer","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0265","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3324\/haematol.2013.084624","article-title":"Manipulation of the hepcidin pathway for therapeutic purposes","volume":"98","author":"Fung","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0270","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/mol.112.083428","article-title":"High-throughput screening of small molecules identifies hepcidin antagonists","volume":"83","author":"Fung","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0275","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1172\/JCI44421","article-title":"Adipocyte iron regulates adiponectin and insulin sensitivity","volume":"122","author":"Gabrielsen","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0280","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/138161206777947614","article-title":"Oxidative stress in hepatic ischemia\u2013reperfusion injury: the role of antioxidants and iron chelating compounds","volume":"12","author":"Galaris","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0285","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/ATVBAHA.113.302381","article-title":"Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population","volume":"34","author":"Galesloot","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0290","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1182\/blood-2011-02-337907","article-title":"Serum hepcidin: reference ranges and biochemical correlates in the general population","volume":"117","author":"Galesloot","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0295","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1039\/C4MT00104D","article-title":"Macrophages: central regulators of iron balance","volume":"6","author":"Gammella","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.beha.2004.08.020","article-title":"Hepcidin\u2014a regulator of intestinal iron absorption and iron recycling by macrophages","volume":"18","author":"Ganz","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0305","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0310","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2009.01.010","article-title":"Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression","volume":"9","author":"Gao","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0320","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jnutbio.2008.07.014","article-title":"The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes","volume":"20","author":"Ge","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-396962-0.00007-0","article-title":"Anticalins small engineered binding proteins based on the lipocalin scaffold","volume":"503","author":"Gebauer","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0330","doi-asserted-by":"crossref","first-page":"459278","DOI":"10.1155\/2012\/459278","article-title":"Alcohol activates TGF-beta but inhibits BMP receptor-mediated Smad signaling and Smad4 binding to hepcidin promoter in the liver","volume":"2012","author":"Gerjevic","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0335","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbagen.2011.10.013","article-title":"Regulation of iron transport and the role of transferrin","volume":"1820","author":"Gkouvatsos","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0340","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.intimp.2008.01.026","article-title":"Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice","volume":"8","author":"Gong","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FJC.0b013e31802c0cd0","article-title":"In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress","volume":"49","author":"Goudeau","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0350","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(24)37605-0","article-title":"In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration","volume":"286","author":"Graham","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0355","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/mnfr.201400036","article-title":"Iron, oxidative stress, and redox signaling in the cardiovascular system","volume":"58","author":"Gudjoncik","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0360","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-16-32","article-title":"Effects of statins on the secretion of human serum albumin in cultured HepG2 cells","volume":"16","author":"Ha","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0365","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jtcvs.2012.09.003","article-title":"Low preoperative hepcidin concentration as a risk factor for mortality after cardiac surgery: a pilot study","volume":"145","author":"Haase-Fielitz","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0370","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3748\/wjg.15.1186","article-title":"Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?","volume":"15","author":"Harrison-Findik","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0380","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.ajkd.2008.10.037","article-title":"Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case\u2013control study","volume":"53","author":"Ho","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0385","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cytogfr.2009.10.021","article-title":"Applications of small molecule BMP inhibitors in physiology and disease","volume":"20","author":"Hong","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0390","doi-asserted-by":"crossref","first-page":"25450","DOI":"10.1074\/jbc.M113.471573","article-title":"Hepcidin bound to alpha2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels","volume":"288","author":"Huang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0395","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.peptides.2012.03.032","article-title":"Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice","volume":"35","author":"Huang","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0400","doi-asserted-by":"crossref","first-page":"e40465","DOI":"10.1371\/journal.pone.0040465","article-title":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes","volume":"7","author":"Ikeda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0405","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jnutbio.2009.04.009","article-title":"Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction","volume":"21","author":"Isoda","year":"2010","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0410","doi-asserted-by":"crossref","first-page":"746","DOI":"10.7326\/0003-4819-159-11-201312030-00007","article-title":"Treatment of anemia in patients with heart disease: a systematic review","volume":"159","author":"Kansagara","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2012.11.013","article-title":"Effect of ferroportin polymorphism on iron homeostasis and infection","volume":"416","author":"Kasvosve","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0420","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcpa.2012.09.001","article-title":"The pathology of comparative animal models of human haemochromatosis","volume":"147","author":"Klopfleisch","year":"2012","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0425","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nbt0996-1112","article-title":"Mirror-image RNA that binds D-adenosine","volume":"14","author":"Klussmann","year":"1996","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.niox.2013.07.002","article-title":"Hydrogen sulfide chemical biology: pathophysiological roles and detection","volume":"35","author":"Kolluru","year":"2013","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0435","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.freeradbiomed.2005.11.004","article-title":"Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case\u2013control study","volume":"40","author":"Kom","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0440","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0450","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/joe.1.05729","article-title":"The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney","volume":"184","author":"Kulaksiz","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0455","doi-asserted-by":"crossref","first-page":"e75518","DOI":"10.1371\/journal.pone.0075518","article-title":"Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform","volume":"8","author":"Laarakkers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0460","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2006.11.014","article-title":"Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques","volume":"42","author":"Lapenna","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0465","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1089\/ars.2011.4271","article-title":"Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action","volume":"18","author":"Lawen","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0470","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s10753-012-9463-4","article-title":"Bacterial cell wall constituents induce hepcidin expression in macrophages through MyD88 signaling","volume":"35","author":"Layoun","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0475","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005344-200207000-00002","article-title":"Intrarenal detection of nitric oxide using electron spin resonance spectroscopy in hypertensive lipopolysaccharide-treated rats","volume":"40","author":"Lecour","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000243792","article-title":"Role of matriptase-2 (TMPRSS6) in iron metabolism","volume":"122","author":"Lee","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0485","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.biochi.2012.07.019","article-title":"Iron increases liver injury through oxidative\/nitrative stress in diabetic rats: involvement of nitrotyrosination of glucokinase","volume":"94","author":"Li","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0490","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.gene.2013.06.034","article-title":"Meta-analyses of HFE variants in coronary heart disease","volume":"527","author":"Lian","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0495","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/oby.2011.12","article-title":"Hemojuvelin: a new link between obesity and iron homeostasis","volume":"19","author":"Luciani","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0500","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.2174\/092986712800609724","article-title":"Chelating agents for the treatment of systemic iron overload","volume":"19","author":"Ma","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0505","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/ars.2007.1893","article-title":"Intracellular iron transport and storage: from molecular mechanisms to health implications","volume":"10","author":"MacKenzie","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0510","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.clinbiochem.2012.05.011","article-title":"Soluble TNFalpha receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients","volume":"45","author":"Martinez-Ruiz","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0515","doi-asserted-by":"crossref","first-page":"e66570","DOI":"10.1371\/journal.pone.0066570","article-title":"High fat diet induces liver steatosis and early dysregulation of iron metabolism in rats","volume":"8","author":"Meli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0520","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1210\/en.2006-1331","article-title":"The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation","volume":"148","author":"Merle","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0525","doi-asserted-by":"crossref","first-page":"37472","DOI":"10.1074\/jbc.M112.358911","article-title":"Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3)","volume":"287","author":"Millonig","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0530","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jb\/mvp148","article-title":"Bone morphogenetic protein receptors and signal transduction","volume":"147","author":"Miyazono","year":"2010","journal-title":"J Biochem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0535","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cca.2011.04.007","article-title":"Hereditary hemochromatosis: laboratory evaluation","volume":"412","author":"Moyer","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0545","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jcp.2010.086991","article-title":"Disorders of iron metabolism. Part II: iron deficiency and iron overload","volume":"64","author":"Munoz","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0540","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/nu5072384","article-title":"Iron: protector or risk factor for cardiovascular disease? Still controversial","volume":"5","author":"Munoz-Bravo","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0550","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0555","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/nure.12044","article-title":"Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases","volume":"71","author":"Nagaraju","year":"2013","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0560","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.20121946","article-title":"Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection","volume":"210","author":"Nairz","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0565","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0570","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0575","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0580","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2011-10-386268","article-title":"A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload","volume":"119","author":"Neufeld","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0585","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cellsig.2003.08.011","article-title":"Signal transduction of bone morphogenetic protein receptors","volume":"16","author":"Nohe","year":"2004","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0590","doi-asserted-by":"crossref","first-page":"896474","DOI":"10.1155\/2011\/896474","article-title":"ER stress and iron homeostasis: a new frontier for the UPR","volume":"2011","author":"Oliveira","year":"2011","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0595","first-page":"1767","article-title":"Hepcidin\u2014minireview","volume":"7","author":"Palaneeswari","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0600","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0605","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0008-6363(95)00155-7","article-title":"Temporal relationships between levels of circulating NO derivatives, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats","volume":"30","author":"Paya","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0610","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0615","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0620","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2007-08-106195","article-title":"Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C\/EBPalpha","volume":"111","author":"Pinto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0625","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1182\/blood-2010-08-299859","article-title":"Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project","volume":"117","author":"Piperno","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0630","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2013-07-515221","article-title":"Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo","volume":"123","author":"Poli","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0635","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","article-title":"Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo","volume":"117","author":"Poli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0640","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.dld.2013.02.019","article-title":"Iron deficiency: from diagnosis to treatment","volume":"45","author":"Polin","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0645","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1172\/JCI57693","article-title":"Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload","volume":"121","author":"Preza","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0650","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/ndt\/gfr387","article-title":"Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass","volume":"27","author":"Prowle","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0655","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbadis.2007.02.006","article-title":"Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart","volume":"1772","author":"Qian","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0660","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2012-04-423715","article-title":"Treatment of erythropoietin deficiency in mice with systemically administered siRNA","volume":"120","author":"Querbes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0665","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.coph.2009.11.005","article-title":"Crosstalk between perivascular adipose tissue and blood vessels","volume":"10","author":"Rajsheker","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0670","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0030-1255356","article-title":"Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease","volume":"30","author":"Ramm","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0675","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2012-07-440743","article-title":"Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis","volume":"120","author":"Ramos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0680","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jcp.24266","article-title":"alpha-2-Macroglobulin: a physiological guardian","volume":"228","author":"Rehman","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0685","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2174\/092986711794927685","article-title":"Pleiotropic effects of cardioactive glycosides","volume":"18","author":"Riganti","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0690","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2012.09.007","article-title":"Carbon monoxide: mechanisms of action and potential clinical implications","volume":"137","author":"Rochette","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0695","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000329951","article-title":"Atrial and vascular oxidative stress in patients with heart failure","volume":"27","author":"Rochette","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0700","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/ATVBAHA.111.240101","article-title":"Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis","volume":"32","author":"Saeed","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0705","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0710","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2012-09-453977","article-title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(\u2212\/\u2212) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia","volume":"121","author":"Schmidt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0715","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/jn\/137.12.2686","article-title":"Retinoic acid modulates hepatic iron homeostasis in rats by attenuating the RNA-binding activity of iron regulatory proteins","volume":"137","author":"Schroeder","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0720","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3892\/mmr.2012.1004","article-title":"Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis","volume":"6","author":"Schubert","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0725","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/gut.2011.241208","article-title":"Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection","volume":"61","author":"Schwarz","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0730","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2012-09-456756","article-title":"The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys","volume":"121","author":"Schwoebel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0735","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood-2011-07-366690","article-title":"Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways","volume":"119","author":"Shin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0740","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjp.0707322","article-title":"Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats","volume":"151","author":"Sicard","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0745","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10715760701885380","article-title":"Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats","volume":"42","author":"Sicard","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0750","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2007-07-100677","article-title":"Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis","volume":"111","author":"Silvestri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0755","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tube.2011.03.003","article-title":"Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin","volume":"91","author":"Sow","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0760","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature11626","article-title":"Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling","volume":"491","author":"Straub","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0765","doi-asserted-by":"crossref","first-page":"e16454","DOI":"10.1371\/journal.pone.0016454","article-title":"Hepcidin is an antibacterial, stress-inducible peptide of the biliary system","volume":"6","author":"Strnad","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0770","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3181\/0703-MR-54","article-title":"Macrophage iron, hepcidin, and atherosclerotic plaque stability","volume":"232","author":"Sullivan","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0775","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ndt\/gfs584","article-title":"A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0780","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0785","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0790","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2008-12-195503","article-title":"Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells","volume":"114","author":"Tanno","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0795","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","article-title":"Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats","volume":"118","author":"Theurl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0800","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","article-title":"Autocrine formation of hepcidin induces iron retention in human monocytes","volume":"111","author":"Theurl","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0805","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jcla.21634","article-title":"Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates","volume":"27","author":"Troutt","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0810","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1038\/sj.onc.1208901","article-title":"JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress","volume":"24","author":"Tsuji","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0815","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.97.15.1461","article-title":"Association between body iron stores and the risk of acute myocardial infarction in men","volume":"97","author":"Tuomainen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0820","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease","volume":"28","author":"van Rhee","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0825","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gene.2005.07.020","article-title":"Hepcidin: iron-hormone and anti-microbial peptide","volume":"364","author":"Verga Falzacappa","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0835","first-page":"42","article-title":"Molecular basis of HFE-hemochromatosis","volume":"5","author":"Vujic","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0840","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/oby.20403","article-title":"Serum hepcidin levels are associated with obesity but not liver disease","volume":"22","author":"Vuppalanchi","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0845","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000362888","article-title":"Physiology of iron metabolism","volume":"41","author":"Waldvogel-Abramowski","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0850","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1017\/S0007114513003413","article-title":"Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice","volume":"111","author":"Wang","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0855","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3748\/wjg.14.1339","article-title":"Increased hepcidin expression in colorectal carcinogenesis","volume":"14","author":"Ward","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0860","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/hep.26706","article-title":"Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression","volume":"59","author":"Wood","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0865","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1039\/c3cp50183c","article-title":"Formaldehyde and methanol formation from reaction of carbon monoxide and hydrogen on neutral Fe2S2 clusters in the gas phase","volume":"15","author":"Yin","year":"2013","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0870","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0875","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/07853890310016342","article-title":"The iron hypothesis of atherosclerosis and its clinical impact","volume":"35","author":"Yuan","year":"2003","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0880","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11248-011-9582-y","article-title":"Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice","volume":"21","author":"Zhang","year":"2012","journal-title":"Transgenic Res"},{"key":"10.1016\/j.pharmthera.2014.09.004_bb0885","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/hep.26490","article-title":"The small molecule, genistein, increases hepcidin expression in human hepatocytes","volume":"58","author":"Zhen","year":"2013","journal-title":"Hepatology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725814001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:51:47Z","timestamp":1759009907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725814001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":177,"alternative-id":["S0163725814001661"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The iron-regulatory hormone hepcidin: A possible therapeutic target?","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}